Results 231 to 240 of about 22,304 (253)

Levonorgestrel

Reactions Weekly, 2013
  +4 more sources

Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device

Obstetrics and Gynecology, 2018
Navdeep Pal, Larissa A Meyer, Diane C Bodurka   +2 more
exaly  

Levonorgestrel

Reactions Weekly, 1994
openaire   +1 more source

Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices

Contraception, 2015
Sabine Moehner
exaly  

Removal of the endocrine disruptors ethinyl estradiol, bisphenol A, and levonorgestrel by subsurface constructed wetlands.

Science of the Total Environment, 2019
J. M. Campos, S. Queiroz, D. M. Roston
semanticscholar   +1 more source

Novel dissolving microneedles for enhanced transdermal delivery of levonorgestrel: In vitro and in vivo characterization

International Journal of Pharmaceutics, 2017
Guilan Quan, Lili Wang, Xin Pan
exaly  

Levonorgestrel-releasing intra-uterine systems as female contraceptives

Expert Opinion on Pharmacotherapy, 2018
G. Grandi, A. Farulla, F. Sileo, F. Facchinetti   +3 more
semanticscholar   +1 more source

Photocatalytic removal of 17α-ethinylestradiol (EE2) and levonorgestrel (LNG) from contraceptive pill manufacturing plant wastewater under UVC radiation

Chemical Engineering Journal, 2012
Viviane Yargeau
exaly  

Levonorgestrel

Reactions Weekly, 2014
openaire   +1 more source

Semaglutide, a once‐weekly human GLP‐1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel

Journal of Clinical Pharmacology, 2015
Christoph Kapitza, Lene Jensen
exaly